To access this video please...

COVID-19: Recent developments and implications on Asthma, COPD and Allergy


What infection risk in general and, specifically, which targeted therapies are important for the following risk groups: patients with Asthma, COPD or allergies?

  • Virology
  • Allergies
  • Asthma
  • COPD


  • Prof. Dr. Mathias Pletz, Jena
    Chair / Institue for Infectiology and Hospital Hygiene, University Hospital Jena
  • Prof. Dr. Oliver Pfaar, Marburg
    Chair/ Section of Rhinology and Allergy
    Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universit├Ąt Marburg
    DGAKI): ext. Board of Directors
  • Prof. Dr. Claus Vogelmeier, Marburg
    Department of Medicine, Pulmonary and Critical Care Medicine
    University Medical Center Giessen and Marburg, Philipps-Universit├Ąt Marburg, Germany
    Global Initiative for Chronic Obstructive Lung Disease (GOLD)
  • Prof. Dr. Roland Buhl
    Head of the Pulmonary Department at Mainz University Hospital
    Global Initiative for Asthma (GINA)


  • Prof. Roland Buhl, Mainz


09.04.2020, 8:00-9:30 pm (CET)

The broadcast will be highly interactive allowing you, the viewer, to send questions directly to the experts via Livechat, which is sure to guarantee lively discussions.